Evidence map›Paper›PMID 33925341›Full record

ReviewInternational journal of molecular sciences2021

ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.

Briana K Shimada, Viola Pomozi, Janna Zoll, Sheree Kuo, Ludovic Martin, Olivier Le Saux

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05246189 (Employment Retention Issues for Patient With Pseudoxanthoma Elasticum), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05246189 completednot on this mapstarted 2022, after this paper: background citation

Employment Retention Issues for Patient With Pseudoxanthoma Elasticum

TypeobservationalSponsorUniversity Hospital, AngersRan2022 to 2022Enrolled99ConditionsPseudoxanthoma Elasticum, EmploymentArmsTelephone Call
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. The effects of elevated phosphate on the kidney - damaging the gatekeeper.Pflugers Archiv : European journal of physiology · 2026
    Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  11. Elevated phosphate levels in CKD - a direct threat for the heart.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  12. Review
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. The basics of phosphate metabolism.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Briana K ShimadaDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96817, USA.ORCID 0000-0003-1521-6966
Viola PomoziInstitute of Enzymology, RCNS, Hungarian Academy of Sciences, 1117 Budapest, Hungary.
Janna ZollDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96817, USA.
Sheree KuoDepartment of Pediatrics, Kapi'olani Medical Center for Women and Children, University of Hawaii, Honolulu, HI 96826, USA.
Ludovic MartinPXE Consultation Center, MAGEC Reference Center for Rare Skin Diseases, Angers University Hospital, 49100 Angers, France.
Olivier Le SauxDepartment of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96817, USA.ORCID 0000-0002-5605-3617
University of Hawaiʻi at Mānoa · USCentre National de la Recherche Scientifique · FRInstitute of Molecular Life Sciences · HU

Funding

TRPA1 Physiology in Diabetes, Metabolic Syndrome, and MetabolismP20GM113134 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI Kathryn Jaques Schunke · 2017 to 2026
$21.5M
NIGMS NIH HHS P20 GM113134NIH HHS P20GM113134OTKA 128003
6 · The paper itself

Abstract

Pathological (ectopic) mineralization of soft tissues occurs during aging, in several common conditions such as diabetes, hypercholesterolemia, and renal failure and in certain genetic disorders. Pseudoxanthoma elasticum (PXE), a multi-organ disease affecting dermal, ocular, and cardiovascular tissues, is a model for ectopic mineralization disorders. ABCC6 dysfunction is the primary cause of PXE, but also some cases of generalized arterial calcification of infancy (GACI). ABCC6 deficiency in mice underlies an inducible dystrophic cardiac calcification phenotype (DCC). These calcification diseases are part of a spectrum of mineralization disorders that also includes Calcification of Joints and Arteries (CALJA). Since the identification of ABCC6 as the "PXE gene" and the development of several animal models (mice, rat, and zebrafish), there has been significant progress in our understanding of the molecular genetics, the clinical phenotypes, and pathogenesis of these diseases, which share similarities with more common conditions with abnormal calcification. ABCC6 facilitates the cellular efflux of ATP, which is rapidly converted into inorganic pyrophosphate (PPi) and adenosine by the ectonucleotidases NPP1 and CD73 (NT5E). PPi is a potent endogenous inhibitor of calcification, whereas adenosine indirectly contributes to calcification inhibition by suppressing the synthesis of tissue non-specific alkaline phosphatase (TNAP). At present, therapies only exist to alleviate symptoms for both PXE and GACI; however, extensive studies have resulted in several novel approaches to treating PXE and GACI. This review seeks to summarize the role of ABCC6 in ectopic calcification in PXE and other calcification disorders, and discuss therapeutic strategies targeting various proteins in the pathway (ABCC6, NPP1, and TNAP) and direct inhibition of calcification via supplementation by various compounds.

Indexed as

5'-NucleotidaseAnimalsATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersCalcification, PhysiologicCalcinosisDiphosphatesGPI-Linked ProteinsHumansJoint DiseasesMicePhosphoric Diester HydrolasesPseudoxanthoma ElasticumPyrophosphatasesRatsVascular Calcification5'-NucleotidaseABCC6 protein, humanAbcc6 protein, mouseATP-Binding Cassette, Sub-Family C ProteinsATP-Binding Cassette TransportersDiphosphatesdiphosphoric acidectonucleotide pyrophosphatase phosphodiesterase 1GPI-Linked ProteinsNT5E protein, humanNt5e protein, ratPhosphoric Diester HydrolasesPyrophosphatasesABCC6calcificationgeneralized arterial calcification of infancypseudoxanthoma elasticumpyrophosphatetherapies

Identifiers

PMID33925341
PMCPMC8123679
OpenAlexW3158834927

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.